Company / Gross Profit per Share
Neogen Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.87
FY2025
5-year range
$1.81 / $4.30
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
#93 of 99
Health Care
What the data says
Among 99 Health Care companies, Neogen is in the bottom 6% for gross profit per share. Gross Profit per Share has fluctuated over the past 10 years, ranging from $1.81 in FY2021 to $4.30 in FY2023.
Based on SEC 10-K filings.
1.87 in FY2025 with a 5-year CAGR of -12.1%.
Declined from $4.30 to $1.87 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- -12.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 99This company $1.87 Sector average $13.98
▼
-86.6% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share decreased 4.0% year-over-year.
- Ranks #93 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2023.
- Lowest gross profit per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.87 | -4.0% |
| FY2024 | $1.95 | -54.7% |
| FY2023 | $4.30 | +135.6% |
| FY2022 | $1.83 | +0.8% |
| FY2021 | $1.81 | -49.2% |
| FY2020 | $3.57 | +9.3% |
| FY2019 | $3.27 | +8.6% |
| FY2018 | $3.01 | -19.2% |
| FY2017 | $3.72 | +12.6% |
| FY2016 | $3.30 | +10.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026